DEF: BNY Mellon High Yield Strategies Fund Announces 2025 Virtual Shareholder Meeting for Trustee Elections

Sentiment:

Annual Meeting Proxy Statement


BNY Mellon High Yield Strategies Fund has scheduled its 2025 Annual Meeting of Shareholders virtually for August 21, 2025, primarily to elect two Class II Trustees and address corporate governance matters.

Summary

  • BNY Mellon High Yield Strategies Fund will hold its Annual Meeting of Shareholders virtually on Thursday, August 21, 2025, at 10:30 a.m. Eastern time.
  • The primary agenda item for the meeting is the election of two Class II Trustees, Ms. Roslyn M. Watson and Ms. Benaree Pratt Wiley, to serve three-year terms; both have been Trustees since the Fund's inception in 1998.
  • Shareholders of record as of June 25, 2025, are eligible to vote, with 72,736,534 shares of beneficial interest outstanding on that date.
  • The Fund's Board of Trustees, composed entirely of Independent Trustees, maintains an oversight role, while day-to-day management is handled by BNY Mellon Investment Adviser, Inc. and Alcentra NY, LLC.
  • KPMG LLP has been re-selected as the independent auditors for the fiscal year ending March 31, 2026, with audit fees for the Fund at $112,600 for FYE March 31, 2025, and $110,300 for FYE March 31, 2024.
  • Aggregate non-audit fees billed by KPMG to the Fund's Service Affiliates were $5,102,266 for FYE March 31, 2025, and $4,074,591 for FYE March 31, 2024.
  • First Trust Portfolios L.P., First Trust Advisors L. P., and The Charger Corporation collectively held 14,232,740 shares, representing 19.57% of the Fund's outstanding shares as of June 25, 2025.
  • The Fund's officers and Trustees, as a group, beneficially owned less than 1% of the Fund's outstanding shares as of June 25, 2025.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, indicating stable corporate governance and routine operations. The emphasis on independent trustees and robust oversight is positive, but there are no new financial or strategic announcements to significantly boost sentiment. The call for shareholder participation to ensure a quorum is a minor operational concern but not indicative of underlying issues.

Positives

  • The Board of Trustees is comprised entirely of Independent Trustees, including the Chairman, which enhances independent oversight and reduces potential conflicts of interest with the Investment Adviser.
  • The Board has established clear oversight roles for risk management, encompassing investment, valuation, issuer and counterparty credit, compliance, and operational risks.
  • The Fund operates with standing Audit, Nominating, Compensation, and Litigation Committees, all primarily composed of Independent Trustees, indicating robust corporate governance structures.
  • The Nominating Committee explicitly considers diversity, including gender, race, or national origin, in evaluating potential Trustee nominees, promoting a broader range of skills and perspectives on the Board.
  • Officers and Trustees complied with all Section 16(a) filing requirements for the fiscal year ended March 31, 2025.

Negatives

  • No specific negative financial or operational results are disclosed, as this proxy statement primarily focuses on corporate governance and the upcoming shareholder meeting.

Risks

  • The Board's risk management oversight is subject to inherent limitations, and it is not possible to eliminate all risks applicable to the Fund.
  • Failure to achieve a quorum at the Annual Meeting would necessitate adjournment and continued solicitation of votes at shareholders' expense.

Future Outlook

The document primarily outlines the agenda and procedures for the upcoming Annual Meeting of Shareholders, focusing on the election of trustees and corporate governance matters. It does not provide specific forward-looking financial guidance or strategic outlook beyond the operational aspects of the meeting and ongoing board oversight.

Management Comments

  • A shareholder may think its vote is not important, but it is vital. By law, the Annual Meeting of Shareholders of the Fund will have to be adjourned without conducting any business if shareholders representing less than a majority of the votes entitled to be cast at the Meeting are present. In that event, the Fund, at shareholders' expense, would continue to solicit votes in an attempt to achieve a quorum. Clearly, your vote could be critical to enable the Fund to hold the Meeting as scheduled, so please return your proxy card or otherwise vote promptly. You and all other shareholders will benefit from your cooperation.
  • The Board's role in management of the Fund is oversight. As is the case with virtually all investment companies (as distinguished from operating companies), service providers to the Fund... have responsibility for the day-to-day management of the Fund, which includes responsibility for risk management.
  • The Board has determined that its leadership structure, in which the Chairman of the Board is not affiliated with the Investment Adviser, is appropriate in light of the specific characteristics and circumstances of the Fund.
  • The Board believes that the significance of each Trustee's experience, qualifications, attributes or skills is an individual matter... and that these factors are best evaluated at the Board level, with no single Trustee, or particular factor, being indicative of Board effectiveness.
  • The Board believes that Trustees need to have the ability to critically review, evaluate, question and discuss information provided to them, and to interact effectively with Fund management, service providers and counsel, in order to exercise effective business judgment in the performance of their duties; the Board believes that its members satisfy this standard.

Industry Context

This proxy statement is typical for a closed-end investment company, focusing on routine corporate governance matters such as the election of trustees and auditor selection. The emphasis on independent trustees and robust oversight aligns with current best practices in the investment funds industry, particularly in response to regulatory scrutiny and investor demand for transparency and accountability. The virtual meeting format reflects a broader industry trend towards leveraging technology for shareholder engagement and efficiency.

Comparison to Industry Standards

  • The Fund's Board composition, with all Trustees being Independent Trustees, exceeds the 1940 Act requirement that at least 40% be independent, aligning with or surpassing best practices for corporate governance in the investment management industry.
  • The explicit consideration of diversity (gender, race, national origin) by the Nominating Committee for Trustee nominees is a progressive practice that aligns with evolving global benchmarks for board composition, aiming to enhance decision-making and representation.
  • The detailed disclosure of compensation for Trustees, including both Fund-specific and aggregate fund complex compensation, provides transparency comparable to leading industry standards for executive and board remuneration.
  • The selection of KPMG LLP, a major global accounting firm, as independent auditors, and the detailed disclosure of audit and non-audit fees, reflects adherence to standard practices for publicly traded investment vehicles.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Assistant SecretaryNALisa M. King2024Appointment to the role.
SecretaryAssistant SecretarySarah S. KelleherApril 2024Promotion/Change in role.
Chief Legal OfficerSenior Managing Counsel of BNYPeter M. SullivanJuly 2021Promotion/Change in role.
PresidentVice PresidentDavid DiPetrillo2021Promotion/Change in role.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Board CompositionAll Trustees, including the Chairman, are Independent Trustees, exceeding the 1940 Act requirement of at least 40% independent trustees.OngoingEnhances independent oversight and reduces potential conflicts of interest, aligning with best governance practices.
Nominating Committee CharterThe Nominating Committee explicitly considers diversity (gender, race, or national origin) as a factor in evaluating potential Trustee nominees.OngoingPromotes a more diverse and potentially more effective Board by broadening the range of skills, experience, and perspectives.
Emeritus Board Member ProgramThe Fund's emeritus program for current Trustees was discontinued.November 2021Streamlines board structure and compensation, potentially reducing long-term liabilities related to emeritus roles.

Legal Proceedings

  • The Fund has a Litigation Committee established to address any potential conflicts of interest between the Fund and the Investment Adviser in connection with potential or existing litigation or other legal proceedings related to securities held by the Fund. No specific new or ongoing litigation is detailed in this document.

Related Party Transactions

  • The Bank of New York Mellon, an affiliate of the Investment Adviser, acts as Custodian for the Fund's assets.
  • Compensation for Trustees is allocated among the Fund and other funds in the BNY Mellon Family of Funds, for which the Investment Adviser or its affiliate serves as investment adviser.
  • Aggregate non-audit fees billed by KPMG to Service Affiliates (entities controlling, controlled by, or under common control with the Investment Adviser that provide ongoing services to the Fund) are disclosed.

Stakeholder Impact

  • Shareholders are directly impacted by the election of Trustees, who are responsible for oversight of the Fund's management. Their vote is crucial for achieving a quorum and avoiding additional solicitation expenses. The virtual meeting format impacts how they participate.
  • Management and Service Providers (BNY Mellon Investment Adviser, Alcentra NY, LLC) have their day-to-day management and risk management responsibilities subject to the Board's oversight. The continued appointment of KPMG as auditors affects their financial reporting processes.
  • Auditors (KPMG LLP) have their engagement confirmed for the next fiscal year, and their fees are disclosed, indicating a continued business relationship.

Next Steps

  • Shareholders are urged to vote and submit proxies in advance of the Annual Meeting by mail, internet, or telephone.
  • Intermediary shareholders must register in advance with Computershare Fund Services by August 14, 2025, 5:00 p.m. ET to attend the virtual meeting.
  • Shareholders wishing to submit questions for the Meeting must do so to BNY Investments by August 14, 2025, 5:00 p.m. ET.
  • The Annual Meeting of Shareholders will be held virtually on August 21, 2025, at 10:30 a.m. Eastern time.
  • The election of two Class II Trustees (Roslyn M. Watson and Benaree Pratt Wiley) will take place at the Annual Meeting.
  • Any other business properly brought before the Meeting will be transacted.
  • Shareholder proposals for the 2026 Annual Meeting must be received by March 11, 2026, for inclusion in the proxy statement (Rule 14a-8), or between February 9, 2026, and March 11, 2026, for presentation without inclusion.

Key Dates

DateDescription
1993Roslyn M. Watson became Principal of Watson Ventures, Inc.
1997Joseph S. DiMartino became Director of CBIZ, Inc.
1998Roslyn M. Watson and Benaree Pratt Wiley began serving as Class II Trustees of the Fund.
1998Joseph S. DiMartino became Chairman of the Board and Class III Trustee of the Fund.
2004Benaree Pratt Wiley became Director of Blue Cross Blue Shield of Massachusetts.
2004Joseph W. Connolly became Chief Compliance Officer of the BNY Mellon Family of Funds and BNY Mellon Funds Trust.
2005Benaree Pratt Wiley became Principal of The Wiley Group.
2006Andrew J. Donohue served as Director of the SEC's Division of Investment Management until 2010.
2007Bradley J. Skapyak became Senior Vice President of The Bank of New York Mellon until 2019.
2008Benaree Pratt Wiley became Director of CBIZ, Inc.
2009Bradley J. Skapyak served as Chief Operating Officer and Director of The Dreyfus Corporation until 2019.
2010Daniel Goldstein became Senior Vice President, Development & Oversight of North America Product, BNY Investments until March 2023.
2010Joseph Martella became Senior Vice President of North America Product, BNY Investments until March 2023.
2011Francine J. Bovich became Class I Trustee of the Fund.
2011Bradley J. Skapyak served as Chairman and Director of Dreyfus Transfer, Inc. until 2019.
2012James Windels became Treasurer of the Fund.
2012Jeff S. Prusnofsky became Vice President and Assistant Secretary of the Fund.
2012Gavin C. Reilly became Assistant Treasurer of the Fund.
2012Robert Salviolo became Assistant Treasurer of the Fund.
2012Robert Svagna became Assistant Treasurer of the Fund.
2012Joseph W. Connolly became Chief Compliance Officer of the Fund.
2012Andrew J. Donohue served as Investment Company General Counsel of Goldman Sachs until 2015.
2014Sarah S. Kelleher became Vice President and Secretary of the Fund.
2015Andrew J. Donohue served as Chief of Staff to the Chair of the SEC until 2017.
2016Lisa M. King became Regulatory Administration Group Manager at BNY Mellon Asset Servicing until June 2023.
2017Andrew J. Donohue served as Of Counsel at Shearman & Sterling LLP until July 2019.
2018Roslyn M. Watson's board membership at American Express Bank, FSB ended.
2018Daniel Goldstein became Head of Product Development of North America Distribution, BNY Investments.
2018Joseph Martella became Head of Product Management of North America Distribution, BNY Investments.
2019David DiPetrillo became President of the Fund.
2019Peter M. Sullivan became Chief Legal Officer, Vice President and Assistant Secretary of the Fund.
2019Andrew J. Donohue became Class III Trustee of the Fund.
2019Andrew J. Donohue became a solo law practitioner.
2019Amanda Quinn became Counsel of BNY until December 2021.
2020Deirdre Cunnane became Vice President and Assistant Secretary of the Fund.
2020Amanda Quinn became Vice President and Assistant Secretary of the Fund.
December 2020Benaree Pratt Wiley's board membership at Blue Cross Blue Shield of Massachusetts ended.
December 2020Peter M. Sullivan became Senior Managing Counsel of BNY until July 2021.
2021Bradley J. Skapyak became Class I Trustee of the Fund.
June 2021Joseph W. Connolly ceased being Chief Compliance Officer of the Investment Adviser.
July 2021Peter M. Sullivan became Chief Legal Officer of the Investment Adviser and Associate General Counsel of BNY.
September 2021Sarah S. Kelleher became Senior Managing Counsel of BNY.
November 2021The Fund's emeritus program for current Trustees was discontinued.
December 2021Deirdre Cunnane became Managing Counsel of BNY.
September 2022Roslyn M. Watson's board membership at Pathfinder International ended.
2022Daniel Goldstein became Vice President of the Fund.
2022Joseph Martella became Vice President of the Fund.
December 2022Joseph Martella became Vice President of the Investment Adviser.
January 2023Andrew J. Donohue became Chair of the Mutual Fund Directors Forum.
February 2023David DiPetrillo became Head of North America Distribution, BNY Investments.
February 2023James Windels became Director of the Investment Adviser.
May 2023Joseph S. DiMartino's directorship at CBIZ, Inc. ended.
June 2023Lisa M. King became Counsel of BNY.
April 2023Daniel Goldstein became Executive Vice President of North America Product, BNY Investments.
April 2023Joseph Martella became Executive Vice President of North America Product, BNY Investments.
March 2024Amanda Quinn became Managing Counsel of BNY.
April 2024Sarah S. Kelleher became Secretary of the Fund.
2024Lisa M. King became Vice President and Assistant Secretary of the Fund.
2024Roberto G. Mazzeo became Assistant Treasurer of the Fund.
December 31, 2024Date for share ownership reporting for Board Nominees and Continuing Trustees.
February 26, 2025Audit Committee approved KPMG LLP as independent auditors for the fiscal year ending March 31, 2026.
March 31, 2025End of the Fund's most recent fiscal year for which financial statements were audited.
May 22, 2025Date of the Report of the Audit Committee.
June 25, 2025Record Date for shareholders entitled to vote at the Annual Meeting.
June 25, 2025Date for beneficial ownership reporting for shareholders owning 5% or more of outstanding shares.
July 15, 2025Estimated mailing date for proxy materials to shareholders of record.
July 15, 2025Date of the Proxy Statement.
August 14, 2025Deadline (5:00 p.m. ET) for intermediary holders to register in advance to attend the virtual meeting.
August 14, 2025Deadline (5:00 p.m. ET) for shareholders to submit questions for the Meeting.
August 21, 2025Date of the Annual Meeting of Shareholders (10:30 a.m. Eastern time).
March 11, 2026Deadline for shareholder proposals to be included in the Fund's 2026 proxy statement (Rule 14a-8).
February 9, 2026Earliest date for shareholder proposals to be presented at the 2026 Annual Meeting (not included in proxy statement).
March 11, 2026Latest date (5:00 p.m. ET) for shareholder proposals to be presented at the 2026 Annual Meeting (not included in proxy statement).
March 31, 2026End of the fiscal year for which KPMG LLP has been selected as independent auditors.
August 20, 2026Reference date for calculating shareholder proposal deadlines if the 2026 Annual Meeting is advanced or delayed by more than 30 days.

Recommendation

hold

Keywords

BNY Mellon High Yield Strategies Fund, SEC Filing, Proxy Statement, DEF 14A, Annual Meeting, Shareholder Meeting, Trustee Election, Corporate Governance, Independent Trustees, Investment Company, Closed-End Fund, Risk Management, Audit Committee, Nominating Committee, KPMG, Shareholder Vote, Fund Management, High Yield Strategies

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.